Altered expression of iron regulatory genes in cirrhotic human livers: Clues to the cause of hemosiderosis?

Laboratory Investigation

Volumn 88, Issue 12, 2008, Pages 1349-1357

  Bergmann, Ottar M ^a   Mathahs, M Meleah ^b   Broadhurst, Kimberly A ^b   Weydert, Jamie A ^a   Wilkinson, Neal ^a   Howe, James R ^a   Han, Okhee ^c   Schmidt, Warren N ^a,b   Brown, Kyle E ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cirrhosis; Divalent metal transporter 1; Ferritin; Ferroportin; Hemochromatosis; Hepcidin

Indexed keywords

FERRITIN; FERROPORTIN; HEPCIDIN; IRON REGULATORY FACTOR; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; TRANSFERRIN;

ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IRON METABOLISM; LIVER CIRRHOSIS; LIVER HEMOSIDEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPECTROMETRY; WESTERN BLOTTING;

APOFERRITINS; BASE SEQUENCE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; DNA PRIMERS; HEMOSIDEROSIS; HUMANS; LIVER CIRRHOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 56649099169     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.95     Document Type: Article

References (38)

1. Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112:882-888.
2. Kayali Z, Ranguelov R, Mitros F, et al. Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis. Liver Int 2005;25:41-48.
3. Ganne-Carrié N, Christidis C, Chastang C, et al. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study. Gut 2000;46:277-282.
4. Brandhagen DJ, Alvarez W, Therneau TM, et al. Iron overload in cirrhosis - HFE genotypes and outcome after liver transplantation. Hepatology 2000;31:456-460.
5. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388:482-488.
6. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000;275:19906-19912.
7. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000;403:776-781.
8. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000;5:299-309.
9. Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. J Biol Chem 1999;274:20826-20832.
10. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82.
11. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-7819.
12. Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-623.
13. Njajou OT, Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-214.
14. Camaschella C, Roetto A, Calí A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
15. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-22.
16. Stuart KA, Anderson GJ, Frazer DM, et al. Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis. Hepatology 2004;39:492-499.
17. Détivaud L, Nemeth E, Boudjema K, et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 2005;106:746-748.
18. Brown KE, Khan CM, Zimmerman MB, et al. Hepatic iron overload in blacks and whites: a comparative autopsy study. Am J Gastroenterol 2003;98:1594-1598.
19. Edwards CQ, Carroll M, Bray P, et al. Hereditary hemochromatosis. Diagnosis in siblings and children. New Engl J Med 1977;297:7-13.
20. Brown KE, Broadhurst KA, Mathahs MM, et al. Expression of HSP47, a collagen-specific chaperone, in normal and diseased human liver. Lab Invest 2005;85:789-797.
21. Hubert N, Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci USA 2002;99:12345-12350.
22. Han O, Kim EY. Colocalization of ferroportin-1 with hephaestin on the basolateral membrane of human intestinal absorptive cells. J Cell Biochem 2007;101:1001-1010.
23. Villeneuve JP, Bilodeau M, Lepage R, et al. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 1996;25:172-177.
24. Emond MJ, Bronner MP, Carlson TH, et al. Quantitative study of the variability of hepatic iron concentration. Clin Chem 1999;45:340-346.
25. Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005;115:2180-2186.
26. Fleming RE, Migas MC, Holden CC, et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci USA 2000;97:2214-2219.
27. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2002;101:2461-2463.
28. Harrison-Findik DD, Schafer D, Klein E, et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 2006;281:22974-22982.
29. Nishina S, Hino K, Korenaga M, et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 2008;134:226-238.
30. Batey RG, Johnston R. Effects of alcohol, carbon tetrachloride, and choline deficiency on iron metabolism in the rat. Alcohol Clin Exp Res 1993;17:931-934.
31. Gentry-Nielsen MJ, Preheim LC, Lyman KN, et al. Use of rat models to mimic alterations in iron homeostasis during human alcohol abuse and cirrhosis. Alcohol 2001;23:71-81.
32. Guyader D, Thirouard AS, Erdtmann L, et al. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol 2007;46:587-595.
33. Yeh KY, Yeh M, Glass J. Hepcidin regulation of ferroportin expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol 2004;286:G385-G394.
34. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2093.
35. Trinder D, Oates PS, Thomas C, et al. Localisation of divalent metal transporter 1 (DMT1) to the microvillus membrane of rat duodenal enterocytes in iron deficiency, but to hepatocytes in iron overload. Gut 2000;46:270-276.
36. Fiorelli G, De Feo TM, Duca L, et al. Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis. Eur J Clin Invest 2002;325:21-27.
37. Zhang AS, Xiong S, Tsukamoto H, et al. Localization of iron metabolism-related mRNAs in rat liver indicates that HFE is expressed predominantly in hepatocytes. Blood 2004;103:1509-1514.
38. Brunt EM, Olynyk JK, Britton RS, et al. Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol 2000;95:1788-1793.